Stock Alert: Zogenix Shares Up 17% In Early Trade On FDA Approval For Fintepla

Shares of Zogenix Inc. (ZGNX) are rising over 17% in pre-market today, after the pharmaceutical company announced that the U.S. FDA has approved FINTEPLA oral solution, CIV for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.

from RTT - Before the Bell https://ift.tt/3eAYnnH
via IFTTT